topical timolol maleate

DRUG2 trials

Sponsors

Unity Health Toronto, Massachusetts General Hospital

Conditions

HemangiomaHereditary Hemorrhagic Telangiectasia

Phase 1

Topical Anti-angiogenic Therapy for Telangiectasia in HHT: Proof of Concept

CompletedNCT01752049

Unity Health TorontoHereditary Hemorrhagic Telangiectasia

Start: 2013-05-31End: 2019-08-30Updated: 2023-09-21

Unknown Phase

A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn

RecruitingNCT01873131

Massachusetts General HospitalHemangioma

Start: 2011-02-28End: 2028-12-31Target: 126Updated: 2023-11-02